Abbott Laboratories (ABT)
$103.72
0.00 (0.00%)
ABT Stock Quote Delayed 30 Minutes
Is It Time to Sell Abbott Labs?
Abbott Labs has been on a tear since October, but its technical strength is wearing thin, plus a few other factors stand to hamper this otherwise solid company.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
181.61B
PE Ratio
32.31
EPS
3.21
Volume (Avg. Vol.)
531
Day's Range
-
52-Week Range
$89.67 - $121.64
Dividend & Yield
$2.04 (1.97%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
13 Ultimate Dividend Stocks
Here are the best of the best: They've been paying dividends for at least 60 years, and for at least 29 years in a row. Plus, their payout is more than ...
4 ETFs to Guard Against Market Volatility
Worried about the market's current uncertainty? A good defensive play right now is low-risk, low-beta ETFs. Here are four of the best.
Glaxo to Pay $3B in Fines for Improper Drug Marketing
GlaxoSmithKline will pay $3 billion in fines relating to its promotion of the antidepressant drugs, Paxil, Wellbutrin and Avandia, and the asthma drug Advair.
Dividends Do Matter in Dud Stocks
For those investors watching their investments lose ground, the dividends really do matter. But ... stock appreciation should make your checklist, too.
Don’t Buy Pharma Stocks — Buy THESE Pharma Stocks
If your sliver of the pharma pie is too small, it's easy to fall into the "any old pharma stock will do" trap. Keep your eye on the prize with these must-own names.
Daffy Mr. Dow Doesn’t Know Where To Go
Markets are not operating on any rational basis, so while waiting for it to sort out, selling Abbott and buying Johnson and Johnson is a good play
My Dividend Crossover Point Process
Investors in dividend stocks need patience and time to get to the point where monthly dividend income exceeds monthly expenses. Now is a good time to start
The Most Successful Dividend Investors of All Time
Dividend investing is as sexy as watching paint dry on the wall, but with patience and a keen eye the strategy can pay off in the long run.
10 Market-Beating, Low-Beta Stocks
High returns from stocks with historically low volatility prove boring can be beautiful -- and in this market, that's a very good thing.
Tough Market? Not for Defensive Stocks
The market has been hit hard since the start of April, but not all sectors have lost ground. Find out what has been working through this difficult tape.
Be Careful Chasing Higher Yielding Stocks
Just because a stock's dividend yield is low is not a reason to chase a higher dividend yield if the stock is still solid and can produce down the road.
5 Triply Tempting Blue-Chip Stocks to Buy
Strong earnings, dividend hikes and price surges make these five blue-chip stocks the belles of the ball.
ETF Alternatives for Last Week’s Hot Stocks
Here are some excellent ETF alternatives to the retail, real estate, coffee, pharmaceuticals and technology stocks that our writers discussed last week.
Mead Johnson: A Formula for Success
The maker of infant formula and pediatric products is a perpetual winner, with strong growth in foreign markets as well.
When Do Share Buybacks Mask Excessive Compensation?
Stock options issued as executive compensation can lead to anti-dilutive share repurchases. Is that always a bad thing? Not necessarily.
Top 10 New Products Flying Off Store Shelves
These items introduced in 2011 reeled in the leading sales, among them Pampers Cruiser/Swaddlers with Dry Max and Nicorette Lozenge.
Abbott Laboratories Is Cheaper Than You Think
Abbott Labs financial statements provide information on earnings per share that suggest the stock is undervalued, with a possible P/E ratio better than market
30 Blue Chips Increasing Dividends in Q1
Income investors, rejoice: Dividend payouts could hit a record-breaking $263 billion this year.
9 Pharma Buys for a Healthy Portfolio
Their dividends are attractive, and some drugmakers have made great progress in refilling their pipelines.
